Olivia Mbitikon

Virological response and resistance profiles after 18 to 30 months of first- or second-/third-line antiretroviral treatment: a cross-sectional evaluation in HIV type 1-infected children living in the Central African Republic.

C. Charpentier, H. Péré, L. Bélec, 2012, AIDS research and human retroviruses.

Usefulness of a genotypic resistance test using dried blood spot specimens in African HIV-infected children with virological failure according to the 2010-revised WHO criteria

C. Charpentier, L. Bélec, P. Tisserand, 2011, Archives of Virology.

High levels of virological failure with major genotypic resistance mutations in HIV-1-infected children after 5 years of care according to WHO-recommended 1st-line and 2nd-line antiretroviral regimens in the Central African Republic

L. Bélec, C. Costiniuk, J. D. D. Longo, 2017, Medicine.

High prevalence of antiretroviral drug resistance mutations in HIV-1 non-B subtype strains from African children receiving antiretroviral therapy regimen according to the 2006 revised WHO recommendations.

C. Charpentier, L. Bélec, G. Grésenguet, 2008, Journal of acquired immune deficiency syndromes.

Priority Activities in Child and Adolescent Tuberculosis to Close the Policy-Practice Gap in Low- and Middle-Income Countries

S. Kabra, R. Triasih, E. Purev, 2022, Pathogens.

Surveillance of Antiretroviral Drug Resistance Mutations in Untreated Young Children Living in the Central African Republic

C. Charpentier, H. Péré, L. Bélec, 2011, Antiviral therapy.

First data on HIV-1 resistance mutations to antiretroviral drugs in Central African Republic.

H. Fleury, P. Pinson, J. Gody, 2010, AIDS research and human retroviruses.

Programmatic Implementation of Contact Investigation in Eight African Countries

Alphazazi Soumana, A. S. Magassouba, G. Badoum, 2022, Tropical medicine and infectious disease.